Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Herzog, Sophia Minou; Ortolano, Lorena Cascant; Brenner, Walburgis et al.

Biomarkers in blood and saliva to screen fragile patients with solid tumors: A systematic review of the literature

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. Bd. 216. 2025


Laackmann, Elena; Riecke, Kerstin; Rachakonda, Sivaramakrishna et al.

Biomarkers in metastatic breast cancer with brain metastases - a subanalysis of matched tumor samples of the BMBC registry

CLINICAL CANCER RESEARCH. Bd. 31. H. 12. 2025


Schmidt, M; Nanda, R

Breast Cancer Immunotherapy

Breast Cancer Immunotherapy. 1. Aufl. Springer 2025


Frenking, Jan H.; Zhou, Xiang; Rejeski, Kai et al.

Bridging intensity is associated with impaired hematopoietic recovery after BCMA CAR-T therapy for multiple myeloma

BLOOD ADVANCES. Bd. 9. H. 16. 2025 S. 4151-4166


Goeller, Stephanie; Schmidberger, Heinz

Can stereotactic radiotherapy for neovascular age-related macular degeneration (STAR trial) enhance quality of life?

STRAHLENTHERAPIE UND ONKOLOGIE. Bd. 201. H. 3. 2025 S. 346-348


Seyringer, Simone; Pilz, Micha Johannes; Jansen, Femke et al.

Cancer-specific utility instrument for health economic evaluations: A synopsis of the EORTC QLU-C10D user manual and current validity evidence

EUROPEAN JOURNAL OF CANCER. Bd. 217. 2025



Worel, Nina; Mooyaart, Jarl E.; Hoogenboom, Jorinde D. et al.

CAR-T cell manufacturing failures and out-of-specification products in the real-world setting: A survey from the EBMT cellular therapy and immunobiology working party

BONE MARROW TRANSPLANTATION. Bd. 60. H. 8. 2025 S. 1184-1186


Leypoldt, Lisa B.; Guo, Linlin; Besemer, Britta et al.

Cardiac biomarkers for risk stratification in newly diagnosed high-risk multiple myeloma in the GMMG-CONCEPT trial

CARDIO-ONCOLOGY. Bd. 11. H. 1. 2025


Denk, Alexander; Fante, Matthias Alexander; Heidenreich, Silke et al.

Changes in Chronic Graft-versus-Host Disease Treatment Over Time: A 15-Years Survey Within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland

TRANSPLANTATION AND CELLULAR THERAPY. Bd. 31. H. 7. 2025 S. 450e1-450e10